1. Home
  2. ECOR vs LSF Comparison

ECOR vs LSF Comparison

Compare ECOR & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • LSF
  • Stock Information
  • Founded
  • ECOR 2005
  • LSF 2015
  • Country
  • ECOR United States
  • LSF United States
  • Employees
  • ECOR N/A
  • LSF N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LSF Packaged Foods
  • Sector
  • ECOR Health Care
  • LSF Consumer Staples
  • Exchange
  • ECOR Nasdaq
  • LSF Nasdaq
  • Market Cap
  • ECOR 39.3M
  • LSF 43.1M
  • IPO Year
  • ECOR 2018
  • LSF 2020
  • Fundamental
  • Price
  • ECOR $5.94
  • LSF $3.62
  • Analyst Decision
  • ECOR Strong Buy
  • LSF Strong Buy
  • Analyst Count
  • ECOR 1
  • LSF 2
  • Target Price
  • ECOR $15.00
  • LSF $4.75
  • AVG Volume (30 Days)
  • ECOR 8.8K
  • LSF 66.5K
  • Earning Date
  • ECOR 08-07-2024
  • LSF 08-07-2024
  • Dividend Yield
  • ECOR N/A
  • LSF N/A
  • EPS Growth
  • ECOR N/A
  • LSF N/A
  • EPS
  • ECOR N/A
  • LSF N/A
  • Revenue
  • ECOR $21,281,000.00
  • LSF $38,299,761.00
  • Revenue This Year
  • ECOR $60.05
  • LSF $21.72
  • Revenue Next Year
  • ECOR $41.34
  • LSF $10.16
  • P/E Ratio
  • ECOR N/A
  • LSF N/A
  • Revenue Growth
  • ECOR 95.83
  • LSF 13.81
  • 52 Week Low
  • ECOR $4.90
  • LSF $0.71
  • 52 Week High
  • ECOR $8.08
  • LSF $6.46
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 46.02
  • LSF 35.36
  • Support Level
  • ECOR $6.00
  • LSF $3.60
  • Resistance Level
  • ECOR $6.28
  • LSF $4.03
  • Average True Range (ATR)
  • ECOR 0.12
  • LSF 0.28
  • MACD
  • ECOR 0.01
  • LSF -0.05
  • Stochastic Oscillator
  • ECOR 19.23
  • LSF 23.60

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: